Deoxycholic acid injections
Injectable deoxycholic acid used by clinicians to reduce submental fat in appropriate candidates after evaluation—not a Quorenne candidacy decision.
Procedure Intelligence is for learning only. It does not decide whether a procedure is right for you—a qualified clinician should review your goals, history, skin, and medications. Important Information
What it is
Injectable deoxycholic acid used by clinicians to reduce submental fat in appropriate candidates after evaluation—not a Quorenne candidacy decision.
Treatment type: Injectable adipocytolytic agent. Performed by a qualified clinician.
Also searched as: Kybella-type education, submental fat injection
Typical U.S. cost
About $800–$3,000 per treatment series
Estimated U.S. range. Actual cost varies by provider, location, treatment area, product/device, and treatment intensity.
This figure is reported as a total treatment cost.
How it generally works
Deoxycholic acid can disrupt fat-cell membranes in the treated fat pad when used as labeled, leading to a localized reduction after healing.
Quorenne does not include operational instructions, device settings, injection maps, dosing, or procedural technique.
What people commonly explore it for
These are topics commonly discussed for this technology—not a match to your skin or a statement that this option is right for you:
- Under-chin fullness
- Body contouring
Areas commonly treated in educational literature include: Under the chin.
What it may not address well
- Fullness driven mainly by loose skin rather than fat
- Large body areas
- Expectations of zero downtime
Additional limitations:
- Not a treatment for general body fat
- Not a substitute for weight management
- Skin laxity may become more noticeable after fat reduction
What the experience may involve
- Assessment of submental fat vs skin laxity
- Multi-session counseling
- Marked swelling phase after treatment
- Follow-up for nerve symptoms and contour
Comfort context: Swelling and tenderness are common topics in consent; comfort plans are clinician-led.
Session pattern: Often discussed as multiple treatment sessions if needed; number and spacing are clinician decisions.
Recovery spectrum: Moderate recovery
Moderate recovery: visible or sensory effects may last longer and can affect social or work plans for some people—discuss expectations with a clinician.
Results and durability
Onset: Contour change is typically gradual as swelling resolves over weeks.
Durability: Fat-cell reduction in treated areas is often discussed as longer-lasting, but aging and weight change still matter.
Results vary. Some effects are temporary. Multiple sessions may sometimes be discussed. Maintenance may be relevant. Individual response cannot be predicted by Quorenne.
Risks and considerations
Common temporary effects
- Significant swelling
- Bruising
- Numbness
- Firmness
Less common but important risks
- Nerve injury affecting smile
- Difficulty swallowing
- Alopecia at injection sites
Rare but serious risks
- Severe infection
- Skin ulceration
Discuss pregnancy, lactation, medications, and medical history with your clinician before any procedure. Quorenne does not declare individual safety.
Skin-tone and pigment considerations
Swelling and temporary marks can look different across skin tones; plan social downtime accordingly.
Inflammation can contribute to pigment change in susceptible skin.
Ulceration or infection pathways can affect scarring risk.
Not an eye-area procedure; facial nerve branches near the treatment field still matter.
More clinical details
Regulatory context
Status label: FDA-approved (indication-specific)
Deoxycholic acid injection is FDA-approved for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Other uses may be off-label.
Regulatory language is indication-, product-, and region-specific. An entire category is not automatically approved for every use.
Questions to ask your clinician
- What are your training and experience with this procedure?
- What product or device would be used?
- Is that use approved or cleared for this indication?
- What alternatives should I consider?
- What risks are most relevant to my medical history and skin tone?
- What results are realistic for someone like me?
- What is the expected recovery?
- How are complications recognized and managed?
- Who will perform the procedure?
- What follow-up is available?
Skincare discussions around procedures
Clinicians often discuss supportive skincare themes. Quorenne does not tell you exactly when to stop or restart medications, prescriptions, retinoids, acids, anticoagulants, supplements, or actives—those decisions belong with the treating clinician.
- Sun protection before and after procedures is commonly discussed
- Barrier support and gentle cleansing are often part of clinician aftercare conversations
- Temporary pauses of certain active ingredients may be discussed—timing is individualized
- Moisturizer use and irritation avoidance are frequently reviewed
- Prescription, medication, and supplement decisions belong with the treating clinician
Related educational support themes:
- Sun protection for healing skin
- Gentle cleansing as directed by clinician
When to seek medical evaluation
- Seek prompt medical care for rapidly changing, painful, bleeding, infected, or otherwise worrisome skin findings.
- Urgent symptoms after any procedure—such as severe pain, vision changes, spreading redness, fever, or breathing difficulty—require emergency care, not Quorenne.
- Quorenne does not triage or diagnose skin conditions.
Evidence and sources
Evidence confidence: Moderate evidence base
Labeled indication trials support educational framing for submental fullness; adverse-event counseling is essential.
Known uncertainties:
- Ideal session number varies
- Long-term skin quality outcomes depend on individual anatomy
Sources
- FDA labeling for deoxycholic acid injection (labeling)
Last reviewed: 2026-08-05
Editorial status: published